Federal Circuit Affirms Infringement Ruling Against Rex Medical in Surgical Stapler Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Intuitive Surgical, Inc. v. Rex Medical, LP |
| Case Number | 24-1125 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District Court |
| Duration | Nov 2023 – Oct 2025 1 year 11 months |
| Outcome | Plaintiff Win – Infringement Affirmed |
| Patents at Issue | |
| Accused Products | Rex Medical’s SureForm Surgical Staplers (SureForm 45 Curved-Tip, SureForm 45, SureForm 60) |
Case Overview
The Parties
⚖️ Plaintiff
A global leader in robotic-assisted minimally invasive surgery, best known for its da Vinci Surgical System, with a substantial patent portfolio in surgical robotics and tools.
🛡️ Defendant
A medical device company with a product line including surgical staplers used in minimally invasive procedures, particularly its SureForm stapler series.
Patents at Issue
This landmark case involved two U.S. patents covering surgical stapling technology, central to Intuitive Surgical’s competitive position:
- • US10136892B2 — Covers innovations in surgical stapling instruments, particularly mechanisms relevant to controlled staple firing and tissue management.
- • US9439650B2 — Addresses structural and functional aspects of surgical stapler design, including key claim elements related to stapler tip geometry and articulation.
Developing a similar surgical device?
Check if your surgical stapler design might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued a clear disposition: AFFIRMED. The court upheld the lower court’s infringement ruling against Rex Medical, LP concerning the SureForm surgical stapler product line. The affirmance applies to the infringement determination tied to both U.S. Patent Nos. US10136892B2 and US9439650B2.
Specific damages amounts were not disclosed in the available case record. Any injunctive relief terms or ongoing royalty structures from the underlying district court proceeding were similarly not detailed in publicly available appellate disposition data.
Verdict Cause Analysis
The verdict cause is recorded as an Infringement Action, affirmed on appeal. While the Federal Circuit’s full written opinion would contain detailed claim construction analysis and evidentiary reasoning, the affirmance itself signals several legally significant conclusions:
Claim Construction Upheld: For a district court infringement finding to survive Federal Circuit review, the lower court’s claim construction must withstand *de novo* appellate scrutiny. An affirmance therefore strongly implies that the district court’s interpretation of the relevant claim terms in both patents was legally sound.
Infringement Analysis Sustained: The accused SureForm stapler products were found to practice the claimed inventions under the affirmed claim constructions. This is particularly notable given the structural specificity typical of surgical device patents.
No Successful Invalidity Defense: The record does not reflect any successful invalidity challenge to either patent. Rex Medical’s inability to invalidate the asserted claims left the infringement finding fully intact on appeal.
Legal Significance
This Federal Circuit affirmance reinforces several important principles for surgical stapler patent litigation and medical device IP more broadly:
- • Robust Claim Drafting Pays Dividends: Intuitive Surgical’s success across both patents suggests well-constructed claims that withstood both infringement-by-design arguments and validity challenges.
- • Appeals Rarely Overturn Infringement Findings: The Federal Circuit’s affirmance rate for district court infringement determinations has historically hovered above 70%, and this case adds to that pattern.
- • Concurrent Multi-Patent Assertion Strengthens Position: Asserting two patents covering overlapping aspects of stapler technology created an interlocking enforcement framework difficult to design around without challenging both patents successfully.
Strategic Takeaways
For Patent Holders:
- • Prosecute continuation applications to build layered patent families around core surgical device innovations.
- • Assert at district level with well-documented claim charts; a clean trial record substantially improves appellate affirmance probability.
For Accused Infringers:
- • Early investment in inter partes review (IPR) proceedings at the USPTO may provide a more efficient invalidity path.
- • Design-around analysis should be initiated at product development stage, not post-complaint, particularly in crowded surgical device patent spaces.
For R&D Teams:
- • Freedom-to-Operate (FTO) analysis must account for continuation patents in a holder’s portfolio, not merely issued patents at time of product launch.
Filing a surgical device patent?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in surgical stapler design. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation in the surgical stapler market.
- View related patents in this technology space
- See which companies are most active in surgical stapler patents
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own surgical stapler technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Curved-tip and articulating stapler geometries
2 Patents at Issue
Key to Intuitive’s position
Strategic Design-Arounds
Possible with careful analysis
✅ Key Takeaways
For Patent Attorneys & Litigators
Federal Circuit affirmance of surgical stapler infringement underscores importance of precise claim construction at district level.
Search related case law →Multi-patent assertion strategy with continuation portfolios creates durable enforcement position.
Explore precedents →For IP Professionals & R&D Leaders
Monitor Intuitive Surgical’s patent portfolio for additional assertion activity in stapler and minimally invasive tool categories.
Start competitive landscape review →FTO analysis must extend to continuation families, not just granted patents at product launch, especially for complex devices.
Start FTO analysis for my product →❓ Frequently Asked Questions
What patents were involved in Intuitive Surgical v. Rex Medical (Case No. 24-1125)?
The case involved U.S. Patent Nos. US10136892B2 (App. No. US15/617835) and US9439650B2 (App. No. US15/018000), both covering surgical stapling instrument technology.
What was the Federal Circuit’s ruling in this case?
The Court of Appeals for the Federal Circuit affirmed the lower court’s infringement finding against Rex Medical, LP on October 2, 2025, upholding claims related to the SureForm surgical stapler product line.
How might this verdict affect surgical stapler patent litigation?
The affirmance strengthens Intuitive Surgical’s enforcement posture in stapler IP and signals elevated litigation risk for competitors developing alternative stapling platforms without comprehensive FTO clearance.
Explore related cases in surgical device and medical robotics patent litigation. Search U.S. Patent Nos. US10136892B2 and US9439650B2 on Google Patents or review case filings on PACER under Case No. 24-1125.
Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.